RG7388 is a novel derivate of cis-imidazoline with improved bioavailability that efficiently induced apoptosis in p53 wild type neuroblastoma cell lines in vitro and blocked tumor growth in xenograft models [139,140,141]. This evidence concerns the gene TP53 and neoplasm.